Risk factor analysis of permanent pacemaker infection

被引:204
作者
Sohail, Muhammad R.
Uslan, Daniel Z.
Khan, Akbar H.
Friedman, Paul A.
Hayes, David L.
Wilson, Walter R.
Steckelberg, James M.
Stoner, Sarah M.
Baddour, Larry M.
机构
[1] Mayo Clin, Coll Med, Dept Med, Div Infect Dis, Rochester, MN USA
[2] Mayo Clin, Coll Med, Div Cardiovasc Dis, Rochester, MN USA
[3] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA
关键词
CARDIOVERTER-DEFIBRILLATOR INFECTION; ANTIBIOTIC-PROPHYLAXIS; MEDICARE BENEFICIARIES; DEVICE INFECTIONS; IMPLANTATION; RATES; MANAGEMENT; BACTEREMIA; DIAGNOSIS;
D O I
10.1086/518889
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Several host- and procedure-related factors have been reported to increase the risk of permanent pacemaker ( PPM) infection on the basis of descriptive analyses of case series. The purpose of this study is to assess the risk factors for PPM infection using case-control study methods. Methods. All patients who had a PPM implanted at our institution from January 1991 to December 2003 were retrospectively reviewed. Each patient who experienced a PPM infection was matched with 2 control subjects by age, sex, year of implantation, and duration of follow-up. Univariate and multivariable analyses were performed to identify significant risk factors for PPM infection. Results. Twenty-nine case patients and 58 control subjects met inclusion criteria. The majority ( 83%) of case patients presented with a pocket infection; a minority ( 10%) had PPM-related endocarditis. Staphylococcus species ( 69%) were the most common pathogens. On univariate analysis, previous PPM infection, malignancy, long-term corticosteroid use, multiple device revisions, a permanent central venous catheter, the presence of > 2 pacing leads, and a lack of antibiotic prophylaxis at the time of PPM placement were associated with an increased risk of PPM infection. A multivariable logistic regression model identified long-term corticosteroid use ( odds ratio [ OR], 13.90; 95% confidence interval [ CI], 1.27 - 151.7; P = .03) and the presence of > 2 pacing leads versus 2 leads ( OR, 5.41; 95% CI, 1.44 - 20.29; P = .01) as independent risk factors for PPM infection. In contrast, use of antibiotic pro phylaxis prior to PPM implantation had a protective effect ( OR, 0.087; 95% CI, 0.016 - 0.48; P = .005). Conclusions. These findings should assist clinicians in identifying patients who are at increased risk of PPM infection, as well as in developing strategies to minimize the modifiable risks.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 19 条
[1]   The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating medicare beneficiaries [J].
Al-Khatib, SM ;
Lucas, FL ;
Jollis, JG ;
Malenka, DJ ;
Wennberg, DE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (08) :1536-1540
[2]  
[Anonymous], INFECT ASS INDWELLIN
[3]   Nonvalvular cardiovascular device-related infections [J].
Baddour, LM ;
Bettmann, MA ;
Bolger, AF ;
Epstein, AE ;
Ferrieri, P ;
Gerber, MA ;
Gewitz, MH ;
Jacobs, AK ;
Levison, ME ;
Newburger, JW ;
Pallasch, TJ ;
Wilson, WR ;
Baltimore, RS ;
Falace, DA ;
Shulman, ST ;
Tani, LY ;
Taubert, KA .
CIRCULATION, 2003, 108 (16) :2015-2031
[4]   Antibiotic prophylaxis with a single dose of cefazolin during pacemaker implantation: Incidence of long-term infective complications [J].
Bertaglia, E ;
Zerbo, F ;
Zardo, S ;
Barzan, D ;
Zoppo, F ;
Pascotto, P .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2006, 29 (01) :29-33
[5]   Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery [J].
Bloom, H ;
Heeke, B ;
Leon, A ;
Mera, F ;
Delurgio, D ;
Beshai, J ;
Langberg, J .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2006, 29 (02) :142-145
[6]   Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999 [J].
Cabell, CH ;
Heidenreich, PA ;
Chu, VH ;
Moore, CM ;
Stryjewski, ME ;
Corey, GR ;
Fowler, VG .
AMERICAN HEART JOURNAL, 2004, 147 (04) :582-586
[7]   Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators [J].
Chamis, AL ;
Peterson, GE ;
Cabell, CH ;
Corey, GR ;
Sorrentino, RA ;
Greenfield, RA ;
Ryan, T ;
Reller, LB ;
Fowler, VG .
CIRCULATION, 2001, 104 (09) :1029-1033
[8]   Diagnosis and management of infections involving implantable electrophysiologic cardiac devices [J].
Chua, JD ;
Wilkoff, BL ;
Lee, I ;
Juratli, N ;
Longworth, DL ;
Gordon, SM .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (08) :604-608
[9]   Antibiotic prophylaxis for permanent pacemaker implantation - A meta-analysis [J].
Da Costa, A ;
Kirkorian, G ;
Cucherat, M ;
Delahaye, F ;
Chevalier, P ;
Cerisier, A ;
Isaaz, K ;
Touboul, P .
CIRCULATION, 1998, 97 (18) :1796-1801
[10]   Current concepts - Treatment of infections associated with surgical implants [J].
Darouiche, RO .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1422-1429